Clinical Trial Update: A Study of LY3872386 in Healthy Participants and Participants With Atopic Dermatitis [Phase 1]

View source ↗

Summary

This Phase 1 study of LY3872386 in healthy participants and individuals with atopic dermatitis was terminated, and results have been posted (2025-10-03).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• LY3872386

Snippet

Sponsor: Eli Lilly and Company | Conditions: Healthy, Atopic Dermatitis | Phase 1 | Status: TERMINATED | Results posted: 2025-10-03